Dexmedetomidine and Neurocognitive Testing in Awake Craniotomy

Journal of Neurosurgical Anesthesiology

Volumn 16, Issue 1, 2004, Pages 20-25

  Mack, Patricia Fogarty ^a   Perrine, Kenneth ^a   Kobylarz, Erik ^a   Schwartz, Theodore H ^a   Lien, Cynthia A ^a  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

Awake craniotomy; Dexmedetomidine; Neurocognitive testing; Sedation

Indexed keywords

ADRENALIN; ALPHA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; ANTIBIOTIC AGENT; BUPIVACAINE; DESFLURANE; DEXAMETHASONE; DEXMEDETOMIDINE; FENTANYL; INHALATION ANESTHETIC AGENT; LIDOCAINE; MANNITOL; MIDAZOLAM; NARCOTIC AGENT; NITROUS OXIDE PLUS OXYGEN; PHENYLEPHRINE; PROPOFOL; REMIFENTANIL; SEDATIVE AGENT; SEVOFLURANE;

ADULT; AGED; ANALGESIA; ARTICLE; BRAIN TUMOR; CASE STUDY; CLINICAL ARTICLE; COGNITION; CONTROLLED STUDY; CRANIOTOMY; DISEASE EXACERBATION; DRUG EFFECT; EPILEPSY; FEMALE; HUMAN; HYPOTENSION; INFUSION; LANGUAGE DISABILITY; LARYNGEAL MASK; MALE; MEDICAL RECORD; NEUROCOGNITIVE TEST; NEUROPSYCHOLOGICAL TEST; PRIORITY JOURNAL; READING; SEDATION; SENSORIMOTOR FUNCTION; TECHNIQUE; TREATMENT INDICATION; VERBAL COMMUNICATION; WAKEFULNESS;

ADRENERGIC ALPHA-AGONISTS; ADULT; AGED; AGED, 80 AND OVER; BRAIN NEOPLASMS; CONSCIOUS SEDATION; CRANIOTOMY; DEUTERIUM OXIDE; DEXMEDETOMIDINE; FEMALE; HUMANS; HYPNOTICS AND SEDATIVES; INTRAOPERATIVE COMPLICATIONS; MALE; MIDDLE AGED; MONITORING, INTRAOPERATIVE; NEUROPSYCHOLOGICAL TESTS; WAKEFULNESS;

EID: 0346962993     PISSN: 08984921     EISSN: None     Source Type: Journal    
DOI: 10.1097/00008506-200401000-00005     Document Type: Article

References (22)

1. Herrick IA, Craen RA, Gelb AW, et al. Propofol sedation during awake craniotomy for seizures: Patient-controlled administration versus neurolept analgesia. Anesth Analg. 1997;84:1285-1291.
2. Herrick IA, Craen RA, Gelb AW, et al. Propofol sedation during awake craniotomy for seizures: Electrocorticographic and epileptogenic effects. Anesth Analg. 1997;84:1280-1284.
3. Hans P, Bonhomme V, Born JD, et al. Target-controlled infusion of propofol and remifentanil combined with bispectral index monitoring for awake craniotomy. Anaesthesia. 2000;55:255-259.
4. Huncke K, Van de Wiele B, Fried I, et al. The asleep-awake-asleep anesthetic technique for intraoperative language mapping. Neurosurgery. 1998;42:1312-1317.
5. Tongier WK, Joshi GP, Landers DF, et al. Use of the laryngeal mask airway during awake craniotomy for tumor resection. J Clin Anesth. 2000;12:592-594,
6. Nelson LE, Ju J, Guo T, et al. The α2-adrenoceptor agonist dexmedetomidine converges on an endogenous sleep-promoting pathway to exert its sedative effects. Anesthesiology. 2003;98:428-436.
7. Bustillo MA, Lazar RM, Finck AD, et al. Dexmedetomidine may impair cognitive testing during endovascular embolization of cerebral arteriovenous malformations: A retrospective case report series. J Neurosurg Anesthesiol, 2002;14:209-212.
8. Ramsay MA, Savage TM, Simpson BR, et al. Controlled sedation with alphaxolone/alphadolone. Br Med J. 1974;2:256-261.
9. Precedex Dexmedetomidine hydrochloride injection. Package insert. Abbott Laboratories, North Chicago, IL, 2001.
10. Johnson KB, Egan TD. Remifentanil and propofol combination for awake craniotomy: case report with pharmacokinetic simulations. J Neurosurg Anesthesiol. 1998;10:25-29.
11. Venn RM, Hell J, Grounds RM. Respiratory effects of dexmedetomidine in the surgical patient requiring intensive care. Crit Care. 2000;4:302-308.
12. Hall JE, Uhrich TD, Barney JA, et al. Sedative, amnestic, and analgesic properties of small-dose dexmedetomidine infusions. Anesth Analg. 2000;90:699-705.
13. Ebert TJ, Hall JE, Barney JA, Uhrich TD, et al. The effects of increasing plasma concentrations of dexmedetomidine in humans. Anesthesiology. 2000;93:382-394.
14. Talke P, Chen R, Thomas B, et al. The hemodynamic and adrenergic effects of perioperative dexmedetomidine infusion after vascular surgery. Anesth Analg. 2000;90:834-839.
15. Arain S, Ebert TJ. The efficacy, side effects, and recovery characteristics of dexmedetomidine versus propofol when used for intraoperative sedation. Anesth Analg. 2002;95:461-466.
16. Bekker AY, Kaufman B, Samir H, et al. The use of dexmedetomidine infusion for awake craniotomy. Anesth Analg. 2001;92:1251-1253.
17. 2 adrenergic agonists and benzodiazepines in rats. Anesthesiology. 1992;76:1004-1011.
18. Thornton C, Lucas MA, Newton DEF, et al. The effects of dexmedetomidine on isoflurane requirements in healthy volunteers. 2: Auditory and somatosensory evoked responses. Br J Anaesth. 1999;83:381-386.
19. Aho M, Lehtinen AM, Erkola O, et al. The effect of intravenously administered dexmedetomidine on perioperative hemodynamics and isoflurane requirements in patients undergoing abdominal hysterectomy. Anesthesiology. 1991;74:997-1002.
20. Aho MS, Erkola OA, Scheinen H, et al. Effect of intravenously administered dexmedetomidine on pain after laparoscopic tubal ligation. Anesth Analg. 1991;73:112-118.
21. Lawrence CJ, DeLange S. Effect of a single pre-operative dexmedetomidine dose on isoflurane requirements and peri-operative haemodynamic stability. Anaesthesia. 1997;52:736-744.
22. Thal GD, Szabo MD, Lopez-Bresnahan M, et al. Exacerbation or unmasking of focal neurologic deficits by sedatives. Anesthesiology. 1996;85:21-25.